找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Symposium on Light-Coagulation; Argon Laser and Xeno Jules François Book 1973 Dr. W. Junk B.V. Publishers 1973 classification.complication.

[复制链接]
查看: 36323|回复: 50
发表于 2025-3-21 19:00:00 | 显示全部楼层 |阅读模式
书目名称Symposium on Light-Coagulation
副标题Argon Laser and Xeno
编辑Jules François
视频video
丛书名称Documenta Ophthalmologica Proceedings Series
图书封面Titlebook: Symposium on Light-Coagulation; Argon Laser and Xeno Jules François Book 1973 Dr. W. Junk B.V. Publishers 1973 classification.complication.
描述The purpose of this symposium on light-coagulation is not to show the superi­ ority of the argon-laser-coagulation or, on the contrary, of the classical photo­ coagulation, but rather to see, if possible, which are the respective indications and contraindications for xenon-are-coagulation as well as for argon-laser­ coagulation. So, for instance, the argon-Iaser-coagulator is perhaps more appropriate to treat the lesions at and around the macula and the optic disc, but for the peripheral lesions of the retina the xenon-arc photocoagulator is surely as effective. For the conservative treatment of intraocular tumours, the xenon­ arc-coagula tor is beyond doubt more efficacious than the argon-Iaser-coagu­ lator. We were very happy to have at this symposium Professor MEYER-SCHWICKE­ RATH, the creator and the pioneer of light-coagulation, his coworker, Professor WESSING, and Doctor HUNTER LITTLE, one of the pioneers of the laser-therapy. We thank them very warmly for having brought to us the results of their promi­ nent clinical experiments. After general considerations on laser-photocoagulation, we will have a discussion on macular alterations and their treatment as well as on peripher
出版日期Book 1973
关键词classification; complication; complications; diabetes; diseases; evaluation; instrumentation; laser; retina;
版次1
doihttps://doi.org/10.1007/978-94-010-2695-6
isbn_softcover978-90-6193-141-6
isbn_ebook978-94-010-2695-6Series ISSN 0303-6405
issn_series 0303-6405
copyrightDr. W. Junk B.V. Publishers 1973
The information of publication is updating

书目名称Symposium on Light-Coagulation影响因子(影响力)




书目名称Symposium on Light-Coagulation影响因子(影响力)学科排名




书目名称Symposium on Light-Coagulation网络公开度




书目名称Symposium on Light-Coagulation网络公开度学科排名




书目名称Symposium on Light-Coagulation被引频次




书目名称Symposium on Light-Coagulation被引频次学科排名




书目名称Symposium on Light-Coagulation年度引用




书目名称Symposium on Light-Coagulation年度引用学科排名




书目名称Symposium on Light-Coagulation读者反馈




书目名称Symposium on Light-Coagulation读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:40:56 | 显示全部楼层
0303-6405 he classical photo­ coagulation, but rather to see, if possible, which are the respective indications and contraindications for xenon-are-coagulation as well as for argon-laser­ coagulation. So, for instance, the argon-Iaser-coagulator is perhaps more appropriate to treat the lesions at and around t
发表于 2025-3-22 02:44:45 | 显示全部楼层
Techniques and Results of Photocoagulation in Non Diabetic Vascular Diseases of the Retina, photocoagulation treatment of these three diseases in 1954. Our experience of about 20 years is mainly based on the use of the xenon arc photocoagulator. However, we have used the argon laser for three years. Especially tiny circumscribed lesions at the posterior pole lend themselves particularly for the smallest argon laser burns.
发表于 2025-3-22 06:44:03 | 显示全部楼层
Macular Diseases: Classification and Treatment with Argon Laser Slit Lamp Photocoagulation, of macular diseases can be based on the pathology as visualized during ophthalmological examination and on histopathologic examination of specimens submitted to the laboratory (., 1967; ., 1965; . et al., 1969). Distinction of the terms retinal detachment, retinal edema, and retinal cysts is requir
发表于 2025-3-22 10:36:53 | 显示全部楼层
Techniques and Results of Photocoagulation in Non Diabetic Vascular Diseases of the Retina,t and rewarding indications for photocoagulation. Encouraged by reports from ., . and . on the favourable influence of diathermy coagulation . started photocoagulation treatment of these three diseases in 1954. Our experience of about 20 years is mainly based on the use of the xenon arc photocoagula
发表于 2025-3-22 15:13:12 | 显示全部楼层
Argon Laser Photocoagulation in Peripheral Retinal Nonvascular Diseases: Retinal Tears, Retinal Deg The absorption properties of retinal pigment epithelium for the argon laser wavelength make argon laser photocoagulation an excellent means to treat retinal tears, retinal degeneration, and retinoschisis. The indications for treatment of these disorders remain complex. Since . first recognized that
发表于 2025-3-22 20:23:36 | 显示全部楼层
Argon Laser Therapy of Diabetic Retinopathy,r 60 % of diabetics develop retinopathy after having had diabetes for 15 or 20 years (. & ., 1968). These data indicate the significance of diabetic retinopathy. Proliferative retinopathy is responsible for blindness in over 90 % of the blind diabetics under 40 (., 1964). Exudative retinopathy accou
发表于 2025-3-22 22:17:56 | 显示全部楼层
Diabetic Retinopathy Treatment with Argon-Coagulation and Xenon-Coagulation,ic retinopathy seems to be one of the major indications of argon-photocoagulation. On the other hand we have to mention that we have several thousand cases treated with xenon-coagulation alone or in combination with argon.
发表于 2025-3-23 04:03:57 | 显示全部楼层
发表于 2025-3-23 08:04:07 | 显示全部楼层
e is changing these markets, we need to assess what digital market platforms will mean for the future of the city’s markets and the traditional brick and mortar sellers. The current research focuses on hyperlocal e-commerce initiatives emerging as alternatives to dominant e-commerce players. Using t
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-13 04:55
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表